Vascular endothelial cells have impaired capacity to present immunodominant, antigenic peptides: A mechanism of cell type-specific immune escape

Journal of Immunology

Volumn 174, Issue 4, 2005, Pages 1947-1953

  Kummer, Marco ^a,b   Lev, Avital ^c   Reiter, Yoram ^c   Biedermann, Barbara C ^a,b  

^a University Hospital Bruderholz   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CYTOKINE; HLA A2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE;

ANTIGEN EXPRESSION; ANTIGENICITY; ARTICLE; CELL CLONING; CELL LINE; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TARGET CELL;

EID: 13544264778     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.4.1947     Document Type: Article

References (28)

1. van den Brink, M. R., and S. J. Burakoff. 2002. Cytolytic pathways in haematopoietic stem-cell transplantation. Nat. Rev. Immunol. 2:273.
2. Dickinson, A. M., X. N. Wang, L. Sviland, F. A. Vyth-Dreese, G. H. Jackson, T. N. Schumacher, J. B. Haanen, T. Mutis, and E. Goulmy. 2002. In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens. Nat. Med. 8:410.
3. + T cells: a mechanism of immunoregulation? J. Immunol. 165:4182.
4. + T-lymphocyte transendothelial migration (diapedesis) in vivo. Blood 103:3111.
5. Dumler, J. S., W. E. Beschorner, E. R. Farmer, K. A. Di Gennaro, R. Saral, and G. W. Santos. 1989. Endothelial-cell injury in cutaneous acute graft-versus-host disease. Am. J. Pathol. 135:1097.
6. Ertault-Daneshpouy, M., C. Leboeuf, M. Lemann, F. Bouhidel, L. Ades, E. Gluckman, G. Socie, and A. Janin. 2004. Pericapillary hemorrhage as criterion of severe human digestive graft-versus-host disease. Blood 103:4681.
7. Biedermann, B. C., S. Sahner, M. Gregor, D. A. Tsakiris, C. Jeanneret, J. S. Pober, and A. Gratwohl. 2002. Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease. Lancet 359:2078.
8. Goulmy, E. 2004. Minor histocompatibility antigens: allo target molecules for tumor-specific immunotherapy. Cancer J. 10:1.
9. Mutis, T., G. Gillespie, E. Schrama, J. H. Falkenburg, P. Moss, and E. Goulmy. 1999. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease. Nat. Med. 5:839.
10. Valitutti, S., S. Muller, M. Dessing, and A. Lanzavecchia. 1996. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J. Exp. Med. 183:1917.
11. Lanier, L. L. 1998. NK cell receptors. Annu. Rev. Immunol. 16:359.
12. + T cells. J. Immunol. 161:2158.
13. Rufer, N., E. Wolpert, C. Helg, J. M. Tiercy, A. Gratwohl, B. Chapuis, M. Jeannet, E. Goulmy, and E. Roosnek. 1998. HA-1 and the SMCY-derived peptide FIDSYICQV (H-Y) are immunodominant minor histocompatibility antigens after bone marrow transplantation. Transplantation 66:910.
14. Gotch, F., A. McMichael, and J. Rothbard. 1988. Recognition of influenza A matrix protein by HLA-A2-restricted cytotoxic T lymphocytes: use of analogues to orientate the matrix peptide in the HLA-A2 binding site. J. Exp. Med. 168:2045.
15. Biedermann, B., A. Rosenmund, M. Muller, H. P. Kohler, A. Haeberli, and P. W. Straub. 1994. Human endothelial cells suppress prothrombin activation in nonanticoagulated whole blood in vitro. J. Lab. Clin. Med. 124:339.
16. Petzelbauer, P., J. R. Bender, J. Wilson, and J. S. Pober. 1993. Heterogeneity of dermal microvascular endothelial cell antigen expression and cytokine responsiveness in situ and in cell culture. J. Immunol. 151:5062.
17. Biedermann, B. C., and J. S. Pober. 1998. Human endothelial cells induce and regulate cytolytic T cell differentiation. J. Immunol. 161:4679.
18. Meadows, L., W. Wang, J. M. den Haan, E. Blokland, C. Reinhardus, J. W. Drijfhout, J. Shabanowitz, R. Pierce, A. I. Agulnik, C. E. Bishop, et al. 1997. The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition. Immunity 6:273.
19. Bednarek, M. A., S. Y. Sauma, M. C. Gammon, G. Porter, S. Tamhankar, A. R. Williamson, and H. J. Zweerink. 1991. The minimum peptide epitope from the influenza virus matrix protein: extra and intracellular loading of HLA-A2, J. Immunol. 147:4047.
20. Cerny, A., P. Fowler, M. A. Brothers, M. Houghton, H. J. Schlicht, and F. V. Chisari. 1995. Induction in vitro of a primary human antiviral cytotoxic T cell response. Eur. J. Immunol. 25:627.
21. Biedermann, B. C., and J. S. Pober. 1999. Human vascular endothelial cells favor clonal expansion of unusual alloreactive CTL. J. Immunol. 162:7022.
22. Takayama, H., G. Trenn, and M. V. Sitkovsky. 1987. A novel cytotoxic T lymphocyte activation assay: optimized conditions for antigen receptor triggered granule enzyme secretion. J. Immunol. Methods 104:183.
23. Biddison, W. E., R. V. Turner, S. J. Gagnon, A. Lev, C. J. Cohen, and Y. Reiter. 2003. Tax and M1 peptide/HLA-A2-specific Fabs and T cell receptors recognize nonidentical structural features on peptide/HLA-A2 complexes. J. Immunol. 171:3064.
24. Epperson, D. E., D. Arnold, T. Spies, P. Cresswell, J. S. Pober, and D. R. Johnson. 1992. Cytokines increase transporter in antigen processing-1 expression more rapidly than HLA class I expression in endothelial cells. J. Immunol. 149:3297.
25. +-ATPase, on CTL-mediated cytotoxicity. J. Immunol. 153:3938.
26. Butz, E. A., and M. J. Bevan. 1998. Differential presentation of the same MHC class I epitopes by fibroblasts and dendritic cells. J. Immunol. 160:2139.
27. + T cell immunodominance in primary and secondary influenza virus infections. J. Exp. Med. 198:399.
28. + T cells. J. Exp. Med. 197:643.